Predictive Oncology Gross Margin 2010-2023 | POAI
Current and historical gross margin for Predictive Oncology (POAI) over the last 10 years. The current gross profit margin for Predictive Oncology as of December 31, 2023 is %.
| Predictive Oncology Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.00B | $0.00B | 100.00% |
| 2023-09-30 | $0.00B | $0.00B | 100.00% |
| 2023-06-30 | $0.00B | 0 | nan% |
| 2023-03-31 | $0.00B | 0 | nan% |
| 2022-12-31 | $0.00B | 0 | nan% |
| 2022-09-30 | $0.00B | 0 | nan% |
| 2022-06-30 | $0.00B | 0 | nan% |
| 2022-03-31 | $0.00B | 0 | nan% |
| 2021-12-31 | $0.00B | 0 | nan% |
| 2021-09-30 | $0.00B | 0 | nan% |
| 2021-06-30 | $0.00B | 0 | nan% |
| 2021-03-31 | $0.00B | 0 | nan% |
| 2020-12-31 | $0.00B | 0 | nan% |
| 2020-09-30 | $0.00B | 0 | nan% |
| 2020-06-30 | $0.00B | 0 | 0.00% |
| 2020-03-31 | $0.00B | 0 | 0.00% |
| 2019-12-31 | $0.00B | 0 | 0.00% |
| 2019-09-30 | $0.00B | 0 | 0.00% |
| 2019-06-30 | $0.00B | 0 | nan% |
| 2019-03-31 | $0.00B | 0 | nan% |
| 2018-12-31 | $0.00B | 0 | nan% |
| 2018-09-30 | $0.00B | 0 | nan% |
| 2018-06-30 | $0.00B | 0 | nan% |
| 2018-03-31 | $0.00B | 0 | nan% |
| 2017-12-31 | $0.00B | 0 | nan% |
| 2017-09-30 | $0.00B | 0 | nan% |
| 2017-06-30 | $0.00B | 0 | nan% |
| 2017-03-31 | $0.00B | 0 | nan% |
| 2016-12-31 | $0.00B | 0 | nan% |
| 2016-09-30 | $0.00B | 0 | nan% |
| 2016-06-30 | $0.00B | 0 | nan% |
| 2016-03-31 | $0.00B | 0 | nan% |
| 2015-12-31 | $0.00B | 0 | nan% |
| 2015-09-30 | $0.00B | 0 | nan% |
| 2015-06-30 | $0.00B | 0 | nan% |
| 2015-03-31 | $0.00B | 0 | nan% |
| 2014-12-31 | $0.00B | 0 | nan% |
| 2014-09-30 | $0.00B | 0 | nan% |
| 2014-06-30 | $0.00B | 0 | nan% |
| 2014-03-31 | $0.00B | 0 | nan% |
| 2013-12-31 | $0.00B | 0 | nan% |
| 2013-09-30 | $0.00B | 0 | nan% |
| 2013-06-30 | $0.00B | 0 | nan% |
| 2013-03-31 | $0.00B | 0 | nan% |
| 2012-12-31 | $0.00B | 0 | nan% |
| 2012-09-30 | $0.00B | 0 | nan% |
| 2012-06-30 | $0.00B | 0 | nan% |
| 2012-03-31 | $0.00B | 0 | nan% |
| 2010-03-31 | $0.00B | 0 | nan% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.005B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.774B | 21.57 |
| Inspire Medical Systems (INSP) | United States | $7.306B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.489B | 0.00 |
| 10x Genomics (TXG) | United States | $3.450B | 0.00 |
| Axonics (AXNX) | United States | $3.420B | 0.00 |
| Enovis (ENOV) | United States | $3.031B | 23.03 |
| Azenta (AZTA) | United States | $2.816B | 229.50 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.644B | 0.00 |
| Privia Health (PRVA) | United States | $2.114B | 93.79 |
| Schrodinger (SDGR) | United States | $1.760B | 0.00 |
| Phreesia (PHR) | United States | $1.275B | 0.00 |
| Omnicell (OMCL) | United States | $1.251B | 30.62 |
| Definitive Healthcare (DH) | United States | $0.829B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.313B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.313B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.147B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.06 |
| Outset Medical (OM) | United States | $0.116B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.115B | 0.00 |
| 111 (YI) | China | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.075B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |